Markets:

Overview

News

Currencies

International

Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

15.68 -0.04 (-0.22%)

Delayed Quote Updated: 3:47 PM EDT, Oct 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

21 22 Next >

This Beaten-Down Growth Stock Has 99% Upside, According to Wall Street ↗

June 12, 2023

A big turnaround could be in the cards for this medical device maker.

Via The Motley Fool

Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review ↗

June 09, 2023

The Nasdaq held near 52-week highs while small caps ramped up.

Via Investor's Business Daily

Stocks That Hit 52-Week Lows On Wednesday ↗

June 07, 2023

On Wednesday, 29 companies set new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023 ↗

June 07, 2023

Via Benzinga

The Latest Analyst Ratings for NovoCure ↗

June 06, 2023

Via Benzinga

Why NovoCure Stock Is Crashing Today ↗

June 06, 2023

Analysts weren't wowed by the company's late-stage data.

Via The Motley Fool

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against NovoCure Limited and Encourages Investors with Losses to Contact the Firm

June 07, 2023

From The Schall Law Firm

Via Business Wire

These 2 Nasdaq Stocks Are Plunging. Here's Why ↗

June 06, 2023

Tuesday brought optimism to the stock market overall, but not for these companies.

Via The Motley Fool

Dow Falls Over 100 Points; Hoth Therapeutics Shares Spike Higher ↗

June 06, 2023

U.S. stocks traded mixed toward the end of trading, with Dow Jones dropping over 100 points on Tuesday. The Dow traded down 0.36% to 33,440.78 while the NASDAQ rose 0.09% to 13,241.04. The S&P 500,...

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against NovoCure Limited and Encourages Investors with Losses to Contact the Firm

June 06, 2023

From The Schall Law Firm

Via Business Wire

NovoCure's Return On Capital Employed Overview ↗

May 18, 2023

Via Benzinga

4 Analysts Have This to Say About NovoCure ↗

May 16, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

June 06, 2023

On Tuesday, 69 stocks hit new 52-week lows.

Via Benzinga

Stocks Mixed As VIX Extends Lows ↗

June 06, 2023

Stocks are struggling for direction midday.

Via Talk Markets

Novocure's Cancer Treating Electric Fields Improves Survival In Lung Cancer Patients, But Stock Tumbles On Remaining Doubts ↗

June 06, 2023

Via Benzinga

Should You Buy Novocure Stock Right Now? ↗

May 05, 2023

Most Wall Street analysts think this stock will skyrocket. They could be right.

Via The Motley Fool

NovoCure (NVCR) Q1 2023 Earnings Call Transcript ↗

May 04, 2023

NVCR earnings call for the period ending March 31, 2023.

Via The Motley Fool

Novocure Stock Dips As Q1 Earnings Miss Estimates, Higher Costs Hurt Bottom Line ↗

May 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 06, 2023

Via Benzinga

Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 06, 2023

Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq.

Via Benzinga

Nasdaq Edges Higher; Joann Shares Plummet ↗

June 06, 2023

U.S. stocks traded mixed midway through trading, with Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.08% to 33,534.50 while the NASDAQ rose 0.27% to 13,265.27. The S&P 500, also...

Via Benzinga

NovoCure: Q1 Earnings Insights ↗

May 04, 2023

Via Benzinga

Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving Lower On Tuesday ↗

June 06, 2023

U.S. stocks traded mixed, with the Nasdaq Composite rising around 0.2% on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Novocure Crashes Almost 30% As Critics Question Its 'Profound' Impact In Lung Cancer Treatment ↗

June 06, 2023

Novocure said its device, Optune, extended overall survival by more than three months for some lung cancer patients.

Via Investor's Business Daily

Dow Drops 50 Points; J.M. Smucker Earnings Top Views ↗

June 06, 2023

U.S. stocks traded lower this morning, with Dow Jones dropping around 50 points on Monday. The Dow traded down 0.16% to 33,509.87 while the NASDAQ fell 0.19% to 13,203.91. The S&P 500, also fell,...

Via Benzinga

Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies

June 06, 2023

From Zai Lab Limited

Via GlobeNewswire

LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies

June 06, 2023

From Novocure

Via Business Wire

Novocure Pledges $3 Million to Conquer Cancer®, the ASCO Foundation, to Support Cancer Research and Education

June 01, 2023

From Novocure

Via Business Wire

3 No-Brainer Stocks to Buy for Under $100 Right Now ↗

May 27, 2023

These stocks might not remain under $100 for too much longer.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023 ↗

May 16, 2023

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

NovoCure Limited - Ordinary Shares (NQ:NVCR)

All News about NovoCure Limited - Ordinary Shares

Starting at /week.